Delivery Order SPE2DR25D1017-SPE2DR26F9CBP
- Not listed
- The Defense Logistics Agency awarded a $1,455.64 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits on October 28, 2025, with completion scheduled for November 19, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award is performed at the contractor's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $2,376.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits, with a completion deadline of January 21, 2026. This non-set-aside contract was awarded on December 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's pharmaceutical supply relationship with the federal government's primary medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Zymfentra 120 mg/ml pen kits, with a contract ceiling value of $1,503.56. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open competition. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025. This delivery...
- The Defense Logistics Agency awarded a $3,007.12 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen kits, with an ultimate completion date of September 25, 2025. This competitive delivery order represents a firm fixed price transaction with no set-aside designation. The award was made on September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,007.12 on September 18, 2025, for the supply of Zymfentra 120 mg/ml pen kits. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 9, 2025, and performance to be fulfilled at the company's Corporate Office location in Conshohocken, Pennsylvania. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceutical and medical supplies for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Zymfentra 120 mg/ml pen kits, with a ceiling value of $1,584.52 and an ultimate completion date of January 2, 2026. This non-set-aside, firm fixed-price delivery order represents a competitive award to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $12,676.16 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zymfentra 120 mg/ml pen kits. This competitive contract represents a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,584.52 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits on November 25, 2025, with an ultimate completion date of December 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The order represents a continuation of pharmaceutical supply services under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen (2-pack) pharmaceutical supplies. This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under a larger indefinite...
- The Defense Logistics Agency awarded a $6,338.08 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Zymfentra 120 mg/ml pen kits with a completion date of January 7, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CBPDelivery Order
The Defense Logistics Agency awarded a $3,169.04 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits, with an ultimate completion date of January 21, 2026. This competitively awarded, firm fixed-price delivery order was issued without set-aside restrictions and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be performed at the company's Conshohocken, Pennsylvania location, supporting the military healthcare supply chain. This delivery order falls under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. The company's position as a pharmaceutical prime vendor underscores its capability to fulfill specialized medical supply needs across the federal government's healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 12/28/25 |